Breaking Down Steve Cohen’s Four Latest Moves in Sarepta Therapeutics (SRPT), Smith & Wesson (SWHC), More

Page 2 of 2

Point72’s current stake in the U.S. market leader in firearms, Smith & Wesson Holding Corp (NASDAQ:SWHC), constitutes 5% of the $803.26 million company’s outstanding stock. The company operates in two segments: firearms and accessories. According to Smith & Wesson Holding Corp (NASDAQ:SWHC)’s investor presentation, 89% of the company’s fiscal third quarter revenue came from the consumer market. The demand of the products varied from sport activities such as hunting, to the personal protection and concealed carry requirements of some customers. The rest of the 11% of revenue came from the professional market including law enforcement and military. Smith & Wesson Holding Corp (NASDAQ:SWHC)’s stock has appreciated by a hefty 60.4% year-to- date. Chuck Royce‘s Royce & Associates and Steve Galbraith’s Herring Creek Capital are two other significant shareholders of the company.

Trillium Therapeutics Inc. (NASDAQ:TRIL) was another one of Cohen’s bets, which contributed towards the health care sector representation of 14% in his portfolio. The developer of immuno-oncology therapies for the treatment of cancer was recently initiated with an ‘Outperform’ rating and a $29 price target by Leerink Swann, with the price target showing 30% upside based on current trading levels. Trillium Therapeutics Inc. (NASDAQ:TRIL)’s stock is up by a staggering 116% year-to-date. According to some analysts, the cancer immunotherapy industry could be valued around $35 billion by 2023. James Flynn’s Deerfield Management also initiated a stake in the company during the first quarter, which comprised 226,046 shares, representing 5.19% of Trillium Therapeutics Inc. (NASDAQ:TRIL)’s outstanding stock.

The $1.07 billion electronics retail stores holding company CONN’S, Inc. (NASDAQ:CONN) is up by 60.78% year-to-date. Its forward earnings multiple stands at 12.79, which is on the higher end of the spectrum in the industry, but so is its PEG ratio of 0.83. In comparison, GameStop Corp.(NYSE:GME), one of CONN’S, Inc. (NASDAQ:CONN)’s industry peers, has a forward multiple of 9.18 and PEG ratio of 0.8. Christian Leone‘s Luxor Capital Group held nearly 7.59 million shares of CONN’S, Inc. (NASDAQ:CONN), according to its latest filing.

Disclosure: None

Page 2 of 2